EyePoint Pharmaceuticals
EYPT
#10609
Rank
C$42.82 M
Marketcap
C$0.51
Share price
0.53%
Change (1 day)
-96.80%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -C$0.43 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are C$2.78 Million. In 2025 the company made an earning of -C$0.33 Billion a decrease over its 2024 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.43 Billion30.34%
2025 -C$0.33 Billion63.24%
2024 -C$0.21 Billion104.29%
2023 -C$98.05 Million-29.88%
2022 -C$0.14 Billion87.2%
2021 -C$74.69 Million38.58%
2020 -C$53.9 Million-24.56%
2019 -C$71.45 Million
2017 -C$32.59 Million22.59%
2016 -C$26.58 Million-8.02%
2015 -C$28.9 Million-296.09%
2014 C$14.73 M-174.02%
2013 -C$19.91 Million37.42%
2012 -C$14.49 Million-56.29%
2011 -C$33.15 Million-1062.38%
2010 C$3.44 M-250.43%
2009 -C$2.29 Million-89.5%
2008 -C$21.81 Million
2005 -C$13.45 Million56.99%
2004 -C$8.57 Million73.7%
2003 -C$4.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$3.06 Million-99.29% Bahamas
NRC Health
NRC
C$20.87 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA